SHERMAN RICHARD MD

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$0
Insider Sells Quantity
16
Insider Sells Sum
$7.65M

Insider Activity of SHERMAN RICHARD MD

The largest sale of all time was on 2012-03-16 and amounted to 52500 shares of ICU Medical, Inc. for $2.52M.

Biography of SHERMAN RICHARD MD

No biography is available at this moment.

2017-03-14SaleICU Medical, Inc.
ICUI
director
3,000
0.0098%
$92.30$276,900+17.7%
2016-10-06SaleICU Medical, Inc.
ICUI
director
3,000
0.0115%
$89.72$269,175+6.18%
2016-09-19SaleICU Medical, Inc.
ICUI
director
6,000
0.0234%
$77.29$463,740+24.07%
2015-08-03SaleICU Medical, Inc.
ICUI
director
3,000
0.0121%
$63.73$191,175+6.79%
2015-04-01SaleICU Medical, Inc.
ICUI
director
3,000
0.0119%
$59.59$178,755+4.21%
2015-01-13SaleICU Medical, Inc.
ICUI
director
17,000
0.0768%
$60.00$1.02M+15.15%
2014-12-22SaleICU Medical, Inc.
ICUI
director
7,500
0.0482%
$83.06$622,925+15.71%
2014-10-20SaleICU Medical, Inc.
ICUI
director
5,134
0.0331%
$70.00$359,380+31.8%
2014-10-17SaleICU Medical, Inc.
ICUI
director
2,366
0.0102%
$46.34$109,646+32.01%
2013-12-18SaleICU Medical, Inc.
ICUI
director
7,500
0.0495%
$65.00$487,531-4.94%
2013-12-09SaleICU Medical, Inc.
ICUI
director
3,100
0.0204%
$65.42$202,800-5.68%
2012-03-16SaleICU Medical, Inc.
ICUI
director
52,500
0.3746%
$48.00$2.52M+18.46%
2012-01-27SaleICU Medical, Inc.
ICUI
director
3,750
0.0216%
$37.41$140,275+15.38%
2011-06-06SaleICU Medical, Inc.
ICUI
director
10,000
0.0723%
$41.27$412,668+7.59%
2005-12-19SaleICU Medical, Inc.
ICUI
director
53
0.0004%
$40.00$2,120+2.19%
2005-12-16SaleICU Medical, Inc.
ICUI
director
9,947
0.07%
$40.00$397,880+1.9%
2003-05-16PurchaseICU Medical, Inc.
ICUI
director
82,801
–
$0$0+5.73%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.